QUEEN MARY UNIVERSITY OF LONDON
๐ฌ๐งUnited Kingdom
- Country
- ๐ฌ๐งUnited Kingdom
- Ownership
- Private
- Established
- 1882-01-08
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.qmul.ac.uk
Hyaluronic Acid and Octenidine Gel as an Adjunct to Non-surgical Periodontal Treatment
Not Applicable
Not yet recruiting
- Conditions
- Wound HealPeriodontal PocketPeriodontal Attachment LossPeriodontitisPeriodontal Inflammation
- Interventions
- Combination Product: Hyaluronic Acid (HA) and Octenidine gelProcedure: Non-surgical periodontal treatment (NSPT)
- First Posted Date
- 2024-07-26
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 26
- Registration Number
- NCT06522438
- Locations
- ๐ฌ๐ง
Centre for Oral Clinical Research (COCR), London, United Kingdom
๐ฌ๐งThe Royal London Dental Hospital, Barts Health NHS Trust, London, United Kingdom
Forensic Facial Reconstruction (FFR) From CT Scans
Completed
- Conditions
- Forensic Facial Reconstruction
- First Posted Date
- 2024-07-11
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 2
- Registration Number
- NCT06496334
- Locations
- ๐ฌ๐ง
Barts School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
The Barts Charity Children's Environmental Health Clinic
Not Applicable
Not yet recruiting
- Conditions
- Asthma in ChildrenEnvironmental IllnessEnvironmental ExposureHealth Behavior
- Interventions
- Behavioral: Exposure mitigations
- First Posted Date
- 2024-06-07
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 200
- Registration Number
- NCT06447974
- Locations
- ๐ฌ๐ง
Queen Mary University of London, London, United Kingdom
Barts Endocarditis Research Registry
Active, not recruiting
- Conditions
- Endocarditis, BacterialInfective EndocarditisEndocarditis
- First Posted Date
- 2024-05-30
- Last Posted Date
- 2024-05-30
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 1000
- Registration Number
- NCT06434012
- Locations
- ๐ฌ๐ง
St Bartholomews Hospital, London, United Kingdom
Oral Cladribine B-cell Study
Completed
- Conditions
- Multiple Sclerosis
- First Posted Date
- 2024-05-16
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 10
- Registration Number
- NCT06415864
- Locations
- ๐ฌ๐ง
Barts Health NHS Trust, London, United Kingdom
Thromboprophylaxis in Lower Limb Immobilisation
Phase 3
Recruiting
- Conditions
- Injury LegThrombosis
- Interventions
- First Posted Date
- 2024-04-17
- Last Posted Date
- 2024-11-29
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 10044
- Registration Number
- NCT06370273
- Locations
- ๐ฌ๐ง
Epsom and St Helier University Hospitals NHS Trust, Carshalton, Surrey, United Kingdom
๐ฌ๐งBarts Health NHS Trust, London, United Kingdom
๐ฌ๐งNorthern Care Alliance NHS Foundation Trust, Manchester, United Kingdom
Air Pollution and Pregnancy
Recruiting
- Conditions
- Premature Birth
- First Posted Date
- 2024-04-02
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 200000
- Registration Number
- NCT06340971
- Locations
- ๐ฌ๐ง
Tina Chowdhury, London, United Kingdom
๐ฌ๐งAnna David, London, United Kingdom
Enhanced Outcome Prediction in Cutaneous Squamous Cell Carcinoma Using Deep-learning and Computational Histopathology
Active, not recruiting
- Conditions
- Squamous Cell Carcinoma of the Skin
- First Posted Date
- 2024-03-25
- Last Posted Date
- 2025-05-01
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 300
- Registration Number
- NCT06327971
- Locations
- ๐ฌ๐ง
Barts Health NHS Trust, London, United Kingdom
Barts Sex-CAD Database - Sex Hormones and Inflammatory Status in Coronary Artery Disease
Recruiting
- Conditions
- Coronary Artery DiseaseMyocardial InfarctionAcute Coronary SyndromeInflammationAtherosclerosis
- First Posted Date
- 2024-03-25
- Last Posted Date
- 2024-07-24
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 6000
- Registration Number
- NCT06327984
- Locations
- ๐ฌ๐ง
Barts Health NHS Trust, London, United Kingdom
ADAs to Alemtuzumab
Active, not recruiting
- Conditions
- Multiple Sclerosis
- First Posted Date
- 2024-03-15
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 15
- Registration Number
- NCT06310343
- Locations
- ๐ฌ๐ง
Barts Health NHS Trust, London, Second Floor Neurophys Dept, United Kingdom
ยฉ Copyright 2025. All Rights Reserved by MedPath